1. Home
  2. ARWR vs CRL Comparison

ARWR vs CRL Comparison

Compare ARWR & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$64.60

Market Cap

10.1B

Sector

Health Care

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$178.50

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARWR
CRL
Founded
2003
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
8.3B
IPO Year
2009
1999

Fundamental Metrics

Financial Performance
Metric
ARWR
CRL
Price
$64.60
$178.50
Analyst Decision
Strong Buy
Buy
Analyst Count
10
13
Target Price
$81.50
$197.58
AVG Volume (30 Days)
2.7M
1.3M
Earning Date
05-08-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
99.80
N/A
EPS
0.22
N/A
Revenue
$16,142,321.00
$1,857,601,000.00
Revenue This Year
N/A
$2.51
Revenue Next Year
N/A
$4.66
P/E Ratio
$287.41
N/A
Revenue Growth
N/A
10.48
52 Week Low
$10.66
$91.86
52 Week High
$76.76
$228.88

Technical Indicators

Market Signals
Indicator
ARWR
CRL
Relative Strength Index (RSI) 51.54 46.92
Support Level $60.53 $145.97
Resistance Level $65.59 $182.81
Average True Range (ATR) 2.68 9.73
MACD 0.01 1.99
Stochastic Oscillator 87.05 84.10

Price Performance

Historical Comparison
ARWR
CRL

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: